AON
60
4
AME
63
-2
CI
42
-3
CCI
36
2
CF
48
3
DAL
74
-2
CAG
34
-3
ALLE
39
-5
AVGO
26
-2
AAL
50
-4
DG
68
13
BMY
73
5
DVA
47
-3
DTE
42
2
CMA
70
2
VIX
40
2
ADP
61
-3
ACN
56
-3
ETN
67
4
BAX
42
-5
AON
60
4
AME
63
-2
CI
42
-3
CCI
36
2
CF
48
3
DAL
74
-2
CAG
34
-3
ALLE
39
-5
AVGO
26
-2
AAL
50
-4
DG
68
13
BMY
73
5
DVA
47
-3
DTE
42
2
CMA
70
2
VIX
40
2
ADP
61
-3
ACN
56
-3
ETN
67
4
BAX
42
-5
Financhill
Back

Rhythm Pharmaceuticals, Inc. 10K Form

Buy
57

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$105.69
Seasonality Move:
-6.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $130.1M
Cash Flow: $-66.6M
Price / Cash Flow: 0
Annual Sales: $2.23
Price / Book: 46.92

Profitability

EPS (TTM): -3.10310
Net Income (TTM): $-192.3M
Gross Margin: $116.1M
Return on Equity: -509.34%
Return on Assets: -47.53%

Rhythm Pharmaceuticals, Inc. Earnings Forecast

Key Rhythm Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 13 years for RYTM is 89.18%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 110.90% of Gross Profit Margin.
  • The Research & Development expenses have been 182.32% of Revenue.
  • The Net Earning history of RYTM is -200.27% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Rhythm Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 1.75
Current Ratio: 4.75
Quick Ratio: 4.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy or a Sell?